What Researchers Did
Researchers investigated whether a distal arterialized venous supercharged (DAVS) flap procedure improved perfusion and survival in an extended dorsal three-perforasome perforator flap rat model.
What They Found
The distal arterialized venous supercharged (DAVS) flap group demonstrated a significantly higher survival rate of 100% compared to 81.93 ± 5.38% in the control group (p < 0.001). All measured blood flow ratios, including those in choke zones, were also significantly higher in the DAVS flap group (all p < 0.05).
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
A primary limitation of this study is its reliance on an animal model, which may not fully translate to human physiology and clinical outcomes.